diaziquone has been researched along with triazinate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylouny, RA; Bissell, EC; Holiat, SM; Hubert, DD; Smith, WE; Sobel, HJ; Watts, LM; Yazdi, E | 1 |
2 other study(ies) available for diaziquone and triazinate
| Article | Year |
|---|---|
Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Pancreatic Neoplasms; Triazines | 1987 |
Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos.
Topics: Animals; Antineoplastic Agents; Asbestos, Serpentine; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mitoxantrone; Models, Animal; Nitrosourea Compounds; Pentostatin; Remission Induction; Survival Analysis; Triazines | 2005 |